BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20043066)

  • 1. Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer.
    Kawase R; Ishiwata T; Matsuda Y; Onda M; Kudo M; Takeshita T; Naito Z
    Int J Oncol; 2010 Feb; 36(2):331-40. PubMed ID: 20043066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer.
    Sato A; Ishiwata T; Matsuda Y; Yamamoto T; Asakura H; Takeshita T; Naito Z
    Int J Oncol; 2012 Aug; 41(2):441-8. PubMed ID: 22580387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.
    Lu D; Yang X; Jiang NY; Woda BA; Liu Q; Dresser K; Mercurio AM; Rock KL; Jiang Z
    Am J Surg Pathol; 2011 Nov; 35(11):1638-45. PubMed ID: 21997684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Lee CS; Gad J
    Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].
    Liao YD; Xu H; Han Q; Lei J; Zhang YY; Wang ZH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):360-4. PubMed ID: 17892132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.
    Chang X; Zhang J; Huang C; Pang X; Luo Q; Zhang H; Zhang S
    Tumour Biol; 2015 Sep; 36(10):7725-33. PubMed ID: 25935536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma.
    Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D
    Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin expression in cervical normal squamous epithelium, cervical intraepithelial neoplasia, and superficially invasive (stage IA1) squamous carcinoma of the cervix.
    Koay MH; Crook M; Stewart CJ
    Pathology; 2014 Aug; 46(5):433-8. PubMed ID: 24977742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF-4E expression is associated with histopathologic grades in cervical neoplasia.
    Lee JW; Choi JJ; Lee KM; Choi CH; Kim TJ; Lee JH; Kim BG; Ahn G; Song SY; Bae DS
    Hum Pathol; 2005 Nov; 36(11):1197-203. PubMed ID: 16260273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma.
    Zhou JH; Ye F; Chen HZ; Zhou CY; Lu WG; Xie X
    Life Sci; 2006 Apr; 78(22):2643-9. PubMed ID: 16434060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical implications of homeobox gene Six1 in cervical cancer cell lines and cervical epithelial tissues.
    Zheng XH; Liang PH; Guo JX; Zheng YR; Han J; Yu LL; Zhou YG; Li L
    Int J Gynecol Cancer; 2010 Dec; 20(9):1587-92. PubMed ID: 21370601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Expression of Aquaporins in Cervical Precursor Lesions and Invasive Cervical Cancer.
    Shen Q; Lin W; Luo H; Zhao C; Cheng H; Jiang W; Zhu X
    Reprod Sci; 2016 Nov; 23(11):1551-1558. PubMed ID: 27140907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix.
    Hsu CG; Wang PH; Ko JL; Chen GD; Chang H; Yang SF; Chen SC; Lin LY
    Int J Gynecol Cancer; 2007; 17(4):851-7. PubMed ID: 17359290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
    Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
    J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolabeling of the inhibin-βA and -βB subunit in normal and malignant human cervical tissue and cervical cancer cell lines.
    Jückstock J; Brüning A; Blankenstein T; Kunze S; Shabani N; Bergauer F; Mylonas I
    Int J Gynecol Cancer; 2010 Oct; 20(7):1117-24. PubMed ID: 21475087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
    Bae DS; Cho SB; Kim YJ; Whang JD; Song SY; Park CS; Kim DS; Lee JH
    Gynecol Oncol; 2001 Jun; 81(3):341-7. PubMed ID: 11371120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
    Pang X; Zhang Y; Zhang S
    Oncol Rep; 2017 Feb; 37(2):831-840. PubMed ID: 28000879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.
    Noel JC; Fernandez-Aguilar S; Fayt I; Buxant F; Ansion MH; Simon P; Anaf V
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1119-23. PubMed ID: 16232183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
    Reesink-Peters N; Hougardy BM; van den Heuvel FA; Ten Hoor KA; Hollema H; Boezen HM; de Vries EG; de Jong S; van der Zee AG
    Gynecol Oncol; 2005 Mar; 96(3):705-13. PubMed ID: 15721415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.